The role of IL-37 in human regulatory T cells
The role of IL-37 in human regulatory T cells
批准号:
10652366
负责人:
Mayumi Fujita
金额:
$59.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-06 至 2026-06-30
关键词:
Anti-Inflammatory AgentsAntigensApplications GrantsAutoimmunityBindingBiologicalBiologyBlood CellsCASP1 geneCell LineCell NucleusCell SeparationCell physiologyCellsClinicalClinical MedicineComplexDNADataDendritic CellsExposure toFOXP3 geneFailureFamily memberFoundationsGenerationsGenetic TranscriptionGraft RejectionHeterogeneityHomeostasisHumanHuman EngineeringIL2RA geneImmuneImmune ToleranceImmune systemImmunosuppressionIn VitroIndividualInflammasomeInflammatoryInterleukin-1InvestigationLaboratory miceMADH2 geneMADH3 geneMaintenanceMediatingMessenger RNAMolecularMusPathologyPatient CarePhenotypeProcessRegulatory T-LymphocyteReportingRoleSignal PathwaySpecies SpecificityT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTranscriptional RegulationTransgenic MiceTransgenic OrganismsTranslatingTranslational RegulationTransplantationTumor Immunityadaptive immune responsecell typeclinical applicationcytokineexposed human populationextracellularforkhead proteinhuman diseasehumanized mousein vivomembermouse modelmutantoverexpressionperipheral bloodperipheral tolerancepharmacologicphenotypic biomarkerpreventpromoterprotein complextissue injurytooltranscription factortransgene expressiontranslational impact
中文摘要
项目摘要/摘要
了解外周耐受和维持免疫系统的动态平衡在
控制人类疾病。我们之前已经证明了抗炎细胞因子IL-37
通过在抗原中产生半成熟的致耐受树突状细胞(DC)参与免疫耐受-
特定的适应性免疫反应。IL-37是IL-1家族的11个成员之一,也是唯一已知的成员
具有广泛的抗炎作用。在我们最近的项目中,我们发现在多名人类中IL-37水平升高
免疫细胞类型,特别是调节性T细胞(Tregs)。进一步的分析表明,人类的特雷格
在所有T细胞亚群中,细胞表达IL-37的水平最高,细胞内表达的IL-37
与人Treg细胞中转录主控因子FOXP3的表达有关。我们目前的情况
该项目假设IL-37表达增加可以稳定Treg细胞并诱导强大的免疫
通过控制FOXP3的表达进行抑制。IL-37在小鼠体内不表达,但使用转基因小鼠和
从人类捐献者的外周血T细胞中,我们产生了强有力的初步数据来支持我们的假设。
在这项拨款提案中,我们将使用人类原代Treg细胞和过表达IL-37和其
突变形式阐明IL-37控制人Treg细胞的生物学和分子机制
功能。因为我们的方案使用了人类T细胞,所以结果可以很容易地转化为临床医学
和病人护理。我们的发现将对许多人类疾病产生巨大的翻译影响,例如
自身免疫和移植。
英文摘要
PROJECT SUMMARY/ABSTRACT
Understanding peripheral tolerance and the maintenance of immune system homeostasis are vital in the
control of human diseases. We have previously demonstrated that anti-inflammatory cytokine IL-37
participates in immune tolerance by generating semi-mature tolerogenic dendritic cells (DCs) in antigen-
specific adaptive immune responses. IL-37 is one of eleven IL-1 family members and the only known member
to be broadly anti-inflammatory. In our recent project, we found IL-37 levels were elevated in multiple human
immune cell types, specifically in regulatory T cells (Tregs) cells. Further analysis revealed that human Treg
cells express the highest IL-37 levels among all T-cell subsets and that intracellular expression of IL-37
correlates with the expression of master transcriptional regulator, FOXP3, in human Treg cells. Our current
project hypothesizes that elevated IL-37 expression stabilizes Treg cells and induces potent immune
suppression by controlling FOXP3 expression. IL-37 is not expressed in mice, but using transgenic mice and
peripheral blood T cells from human donors, we generated strong preliminary data to support our hypothesis.
In this grant proposal, we will use human primary Treg cells and T cell lines overexpressing IL-37 and its
mutant form to elucidate the biological and molecular mechanisms of IL-37 in controlling human Treg cell
function. Since our proposal uses human T cells, the results could be easily translated into clinical medicine
and patient care. Our findings will have an immense translational impact on many human diseases such as
autoimmunity and transplantation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Ethanol Metabolism and Melanoma.
乙醇代谢和黑色素瘤。
DOI:
10.3390/cancers15041258
发表时间:
2023-02-16
期刊:
Cancers
影响因子:
5.2
作者:
[]
通讯作者:
Ethanol-induced skin changes
-
批准号:10478153
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
Ethanol-induced skin changes
-
批准号:10304053
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
The role of IL-37 in human regulatory T cells
-
批准号:10298893
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
The role of IL-37 in human regulatory T cells
-
批准号:10445346
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
Modulation of Inflammasome-mediated cytokine activation by EGCG in human melanoma
-
批准号:9462554
-
项目类别:
-
资助金额:$4.97万
-
财政年份:2016
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:10451489
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8698262
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8334977
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8511336
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8803260
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:10045562
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Developing a protocol for profiling blood markers of melanoma
-
批准号:7546951
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2008
-
负责人:Mayumi Fujita
-
依托单位:
Developing a protocol for profiling blood markers of melanoma
-
批准号:7685271
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2008
-
负责人:Mayumi Fujita
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: